Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences High-Content and Phenotypic Screening Europe 2018

Gary Gintant's Biography



Gary Gintant, Senior Research Fellow, Abbvie

Dr. Gary Gintant is Senior Research Fellow in the Dept. of Integrative Pharmacology, Integrated Science and Technology, at AbbVie. He is involved in multiple internal drug discovery and safety initiatives internally; external activities include various cardiac safety initiatives (such as ILSI/HESI Proarrhythmia Models Project, the Cardiac Safety Research Consortium, and the Comprehensive in Vitro Proarrhythmia Assay Initiative) while serving on various journal editorial boards, NIH study sections, and Safety Pharmacology Society committees. Research interests include cardiovascular pharmacology, cellular electrophysiology/ion channels, arrhythmias, application of stem-cell derived cells and tissues to drug discovery efforts, and translational medicine. He gained his MA, M.Phil. and PhD degrees from the College of Physicians and Surgeons of Columbia University.

Gary Gintant Image

Stem Cell Derived Cardiomyocytes in Drug Discovery and Development: What We’ve Learned, and What We Are Going to Learn

Thursday, 24 May 2018 at 09:45

Add to Calendar ▼2018-05-24 09:45:002018-05-24 10:45:00Europe/LondonStem Cell Derived Cardiomyocytes in Drug Discovery and Development: What We’ve Learned, and What We Are Going to LearnHigh-Content and Phenotypic Screening Europe 2018 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com

After nearly a decade of studies, we have learned much about human induced pluripotent stem-cell derived cardiomyocytes.  This presentation will discuss various key findings with these evolving preparations as related to cardiac safety and drug discovery, citing new initiatives and challenges for continuing progress from pharmaceutical and regulatory perspectives over the next decade.


Add to Calendar ▼2018-05-24 00:00:002018-05-25 00:00:00Europe/LondonHigh-Content and Phenotypic Screening Europe 2018High-Content and Phenotypic Screening Europe 2018 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com